tilizing Next Generation Sequencing to Evaluate Genomic Complexity in Thai Patients with Multiple Myeloma

Phase 1

Completed

• Conditions: Somatic mutation; The newly diagnose with MMThe newly diagnose with plasma cell disorderRelapse MM patientThai population; Multiple Myeloma; Next Generation Sequencing

• Registration Number: TCTR20211020003
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-08-31
• Study Start: 2021-10-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

1. Patient have never been diagnosed or treated with other malignancies before diagnosed with MM.
2. Patients should receive the treatment of multiple myeloma and the medical history must be recorded belong to Siriraj hospital.

Exclusion Criteria

Patient who cannot do bone marrow aspiration.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mutated gene 12 month Next Generation Sequencing

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A